Swiss startup Planetary has secured CHF 16 million ($20 million) in a Series A financing round, alongside CHF 6 million ($7.5 million) in credit, to enhance its fermentation infrastructure and licensing platform for mycoprotein production. The company aims to establish a sustainable food system through its dual business model of selling mycoprotein as a B2B ingredient and licensing its fermentation technology globally.
Planetary's strategic approach to controlling the full value chain, particularly through its two-pronged business model of in-house mycoprotein production and BioBlocks fermentation technology licensing, highlights a significant market shift towards self-sufficiency and cost-efficiency in the alternative protein sector. This model enables Planetary to maintain gross-margin positive operations and offers a blueprint for reducing dependencies and enhancing scalability in foodtech ventures. For professionals tracking investment opportunities, Planetary's focus on owning or co-owning production infrastructure could signal a promising direction for future investments in the fermentation and alternative protein landscape.